#United States #Redwood City #Biotricity #Cardiac Monitoring #B-Secur

Biotricity and B-Secur's Innovative Partnership

In a significant development in the healthcare sector, Biotricity Inc., renowned for its remote cardiac monitoring solutions, has partnered with B-Secur, a frontrunner in biosensing technology. This collaboration aims to launch a state-of-the-art, device-neutral platform designed for comprehensive ambulatory cardiac monitoring.

Combining B-Secur's HeartKey® technology, which features an impressive suite of FDA-cleared algorithms and analytics, with Biotricity's diagnostic solutions, this new platform is poised to empower various healthcare entities. Integrated Delivery Networks, healthcare providers, health systems, and Independent Diagnostic Testing Facilities will have access to enhanced capabilities for monitoring patients remotely.

Dr. Waqaas Al-Siddiq, founder and CEO of Biotricity, emphasized the crucial need for such advanced monitoring systems in today's rapidly evolving healthcare landscape. He stated, "This partnership underscores the need for robust cardiac monitoring solutions in a rapidly evolving healthcare landscape. By working with B-Secur, we aim to address critical gaps in cardiac care delivery, improving accessibility and efficiency for healthcare providers and patients alike."

The urgency for improved cardiac care solutions is accentuated by alarming statistics: nearly 90% of U.S. adults are at risk of developing cardiovascular disease (CVD), and there is a looming deficit of up to 124,000 physicians by the year 2034. Furthermore, the financial implications of CVD are expected to triple, reaching an astounding $1.8 trillion by 2050.

Tyeler Dean, VP of Medical at B-Secur, highlighted the potential benefits of early detection in reducing the risk of heart attack and stroke by over 80%. He stated, "We are at a pivotal moment in cardiac care. Early detection and timely intervention can reduce the risk of heart attack and stroke by over 80%. This gap must be addressed to keep pace with the increasing reliance on proactive cardiac management."

Through HeartKey®, healthcare professionals can access accurate and actionable insights, enabling them to deliver timely and personalized care. The collaboration between Biotricity and B-Secur marks a crucial stride forward in enhancing the accessibility and precision of cardiac monitoring solutions. This initiative not only addresses the pressing resource constraints but also promises improved patient outcomes.

About B-Secur

B-Secur is known for its cutting-edge biosensing technology, dedicated to elevating health monitoring standards through innovative on-device and cloud applications. Their signal processing capabilities offer medical-grade ECG data, enabling quicker and more confident diagnosis and management of health conditions, supported by their ISO 13485:2016 certification.

About Biotricity Inc.

Biotricity is transforming the healthcare market by narrowing the gap in remote monitoring and chronic care management. With a reputation for reliability, Biotricity's solutions for preventive personal care cater to both the medical and consumer sectors. Their commitment is towards developing holistic remote health monitoring systems tailored for chronic conditions. To explore their offerings, visit www.biotricity.com.

In conclusion, the partnership between Biotricity and B-Secur signifies a transformative approach to cardiac health, focusing on early detection and intervention to ensure a healthier future for many. Through such innovative collaborations, the healthcare industry can hope for enhanced standards of care, ultimately benefiting patients across diverse settings.